Cancer Development Current Events | Cancer Development News | 4
|
| Page
4 of
106 |
2104 Results |
|
|
|
Sort By:
Page Views | Date |
Study finds multiple markers for breast and ovarian cancer
Scientists from the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR) have made a promising discovery that could improve the early diagnosis of breast and ovarian cancers through a simple blood test. view more (2005-08-01)
Compounds found in cruciferous vegetables block lung cancer progression
A family of compounds found in cruciferous vegetables, such as broccoli, cauliflower, and watercress, blocked lung cancer progression in both animal studies and in tests with human lung cancer cells. view more (2005-09-15)
New target for cancer therapy identified
A new target for cancer therapy has been identified by Monash University scientists investigating the cell signalling pathways that turn on a gene involved in cancer development. view more (2006-09-22)
Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy
For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease. view more (2009-09-24)
Uveal melanoma patients at higher risk for colon cancer
Higher Colon Cancer Risk in Uveal Melanoma Patients and Their Relatives Compared to General Population, will be presented by Frederick H. Davidorf, MD, during the Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting in Fort Lauderdale, Fla. view more (2007-05-09)
Breast cancer drug receives FDA approval
A new use for the breast cancer drug Herceptin was approved by the FDA yesterday, a move that means more treatment options for the 25 percent of breast cancer patients with early-stage HER-2 positive breast cancer. view more (2006-11-20)
UroGene and Pierre Fabre Médicament sign letter of intent
UroGene S.A. (Evry Génopole - France) and Pierre Fabre Médicament announced today the signature of a letter of intent for a three year collaboration to discover and develop new active compounds against a biological target identified by UroGene in advanced prostate cancer. This target is a cell surface protein which is elevated in... view more... (2002-01-28)
Chemotherapy and tamoxifen reduce risk of second breast cancer
Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online December 25 in the Journal of the National Cancer Institute. The risk reduction persisted for at least 10 and 5 years, respectively. view more (2007-12-26)
Genetic parallels found between lung development and lung cancer
For over 100 years, biologists have speculated that cancer growth shares common features with embryonic development. view more (2006-07-05)
Cancer Cell Detection Technology Wins Kaye Award For Hebrew University Researchers
A unique technology for optoelectronic detection of the presence of cancer cells has been developed at the Hebrew University of Jerusalem by a team of researchers headed by Itamar Willner, Enrique Berman Professor of Solar Energy at the Institute of Chemistry. The technology detects the presence of telomerase, an active enzyme appearing in cancer... view more... (2004-06-20)
Cholesterol levels and use of lipid-lowering drugs are not associated with breast cancer risk
Cholesterol levels and use of statins or other lipid-lowering drugs are not associated with breast cancer risk, according to a study in the October 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. view more (2005-10-25)
Genetic double-agents unmasked
Babraham Institute and Cancer Research UK scientists have discovered that certain enzymes with a key activity in the immune system may be important in stem-cell development, but may also work against us by contributing to the occurrence of cancer. view more (2004-10-26)
VBI researchers develop new method for breast cancer biomarker discovery
Three researchers from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed and evaluated a new one-step bioanalytical approach that allows them to profile in detail complex cellular extracts of proteins. view more (2009-06-10)
Women smokers have higher risk of lung cancer than men smokers, though lower lung cancer death rate
Women who smoke appear to be more susceptible to lung cancer than men who smoke, though women smokers have a lower rate of lung cancer-related death. view more (2006-07-12)
Newly Identified Gene Activated In 80% Of Breast Cancer Patients
New research, published this week in Breast Cancer Research, could provide a genetic explanation for breast cancer. A George Washington University Medical Center team, led by Patricia Berg, has discovered that the gene BP1 is activated in 80% of breast cancer patients. The researchers believe that this gene may offer a useful new target for early... view more... (2003-04-25)
In 'Spontaneous' Liver Cancer, Researcher Sees a Cure
Adding more good news to last week's announcement that Nexavar® (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may "spontaneously" cause liver cancer. view more (2007-06-20)
USC study in Nature Genetics supports a stem cell origin of cancer
Researchers at the University of Southern California (USC) recently made significant strides toward settling a decades-old debate centering on the role played by stem cells in cancer development. view more (2007-01-10)
Media Invitation: 2nd ESMO Scientific & Educational Conference (ESEC)
Scheduled Press Conferences view more (2005-05-17)
Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
A colon cancer researcher at the Ireland Cancer Center of University Hospitals Case Medical Center (UHCMC) has laid out the roadmap for how medical science should employ aspirin and new aspirin-like drugs for use in preventing colon cancer in certain high-risk individuals. view more (2007-05-24)
Jefferson researchers uncover genetic signature that predicts colon cancer
Researchers at Jefferson Medical College in Philadelphia have uncovered a genetic "signature" that accurately identifies colon cancer-a key, they hope, to better understand how the cancer develops. view more (2006-04-05)
|
|
| Page
4 of
106 |
2104 Results |
|
|
|
Sort By:
Page Views | Date |
|
